Objective: Hyperglycemia is associated with worsened clinical outcomes after central nervous system injury. The purpose of this study was to examine the association between lower extremity weakness (LEW) and the glucose levels of blood and cerebrospinal fluid (CSF) in patients undergoing multibranched endovascular aneurysm repair (MBEVAR) of thoracoabdominal and pararenal aortic aneurysms.
Paraplegia remains one of the most devastating complications after endovascular repair of descending thoracic aortic aneurysms and thoracoabdominal aortic aneurysms (TAAAs). Risk factors for spinal cord ischemia (SCI) after endovascular repair of thoracic aortic diseases include prior history of aneurysm repair, increased length of aortic coverage, hypotension, coverage of important collateral vessels (subclavian and internal iliac arteries), and a "shaggy" aorta prone to embolization. [1] [2] [3] [4] [5] [6] [7] [8] Multimodal strategies to improve spinal cord perfusion have decreased the paraparesis and paraplegia rates. 4, 9, 10 Despite these measures, paraplegia still occurs in approximately 5% to 10% of patients undergoing endovascular TAAA repair. 4, 7, 8 Hyperglycemia is associated with worsened clinical outcomes in the setting of acute ischemic stroke, severe head injury, and subarachnoid hemorrhage. [11] [12] [13] [14] [15] [16] [17] It is not clear whether hyperglycemia is a marker for increased severity of neurologic damage or whether it contributes to secondary injury. Proposed mechanisms by which hyperglycemia could be harmful include free radical formation and oxidative injury, loss of selective membrane permeability and calcium homeostasis, triggering of inflammatory and apoptotic pathways, and increased production of lactic acid with reduced tissue pH. [18] [19] [20] [21] [22] [23] Experimental data in animals suggest that hyperglycemia may play a deleterious role in the setting of spinal cord ischemic injury; however, prospective human studies are lacking. [24] [25] [26] The purpose of this study was to examine the association between lower extremity weakness (LEW) and the glucose levels of blood and cerebrospinal fluid (CSF) in patients undergoing multibranched endovascular aneurysm repair (MBEVAR) of pararenal aortic aneurysms (PRAAs) and TAAAs.
METHODS
In July 2005, we began a prospective clinical trial of endovascular repair of PRAAs and TAAAs using a modular multibranched aortic stent graft (Cook Australia, Brisbane, Australia) under a physician-sponsored investigational device exemption approved by the Food and Drug Administration and the Committee on Human Research at the University of California, San Francisco. All patients provided informed consent. Details of the technique as well as inclusion and exclusion criteria have been previously described. 27, 28 Data on demographics, operative repair, complications, and clinical outcomes were recorded prospectively. Aneurysm extent was determined using the Crawford classification system. All patients underwent computed tomography angiography before hospital discharge. Clinical evaluation and computed tomography angiography were performed at 1 month, 6 months, and 12 months postoperatively and then yearly thereafter.
The neurologic examination was performed on a daily basis by the surgical team and the attending surgeon. Any change in the neurologic examination findings was assessed by the attending surgeon. LEW was a predefined adverse event and was assessed perioperatively and at all postoperative visits. The onset of LEW was defined as intraoperative if the patient awoke from anesthesia with a neurologic deficit. It was defined as postoperative if the patient had normal neurologic examination findings on awakening from anesthesia but subsequently developed a neurologic deficit. If the neurologic deficit resolved within 30 days from the day of surgery, LEW was considered transient. Any neurologic deficit lasting beyond 30 days from the day of surgery (regardless of severity) was considered persistent. Paraplegia was defined as the inability to stand without assistance. Patients who required assistance to stand or to walk were defined as having paraparesis.
All patients were admitted to the hospital the night before the procedure and hydrated with intravenous fluids. Antihypertensive medications were routinely withheld perioperatively. Prograde flow to the subclavian or hypogastric arteries was preserved whenever possible. All patients underwent placement of a lumbar catheter preoperatively for drainage of CSF. CSF was drained at a rate of 10 mL/h intraoperatively, with an additional 10 mL of drainage just after the insertion of the final branch of the stent graft. CSF was drained at 10 mL/h for at least the first 24 hours postoperatively.
Patients who developed LEW were treated with prompt additional CSF drainage (up to 50 mL in 60 minutes) until symptoms improved or the onset of headache. Administration of intravenous fluids or blood products was performed concomitantly to augment the blood pressure. Vasopressors were administered only if the patient continued to be symptomatic and hypotensive despite these maneuvers, with a target systolic blood pressure of 180 mm Hg.
In October 2013, we began collecting both blood and CSF in all patients undergoing MBEVAR. Blood and CSF samples were collected preoperatively, immediately after aneurysm repair, and on postoperative day 1 (POD 1). Blood samples were collected on fasting patients from an indwelling arterial catheter and centrifuged at 3000 rpm for 15 minutes, then stored in aliquots at À80 C until the time of analysis. CSF samples were collected on fasting patients from an indwelling lumbar catheter, centrifuged at 2000 rpm for 10 minutes, and stored in aliquots at À80 C until the time of analysis. All sample analysis was performed by the UCSF Clinical Laboratories using the Synchron System (Beckman Coulter, Inc, Brea, Calif). For evaluation of glucose levels, serum and CSF samples were analyzed by an oxygen rate method employing a Beckman Coulter oxygen electrode. The analytic range was 10 to 600 mg/dL with a within-run coefficient of variation (%CV) of 2.0 and total %CV of 3.0. Examination of lactate levels in CSF was performed using an enzymatic assay. The analytic range was 0.3 to 11.0 mmol/L, with a within-run %CV of 3.0 and total %CV of 4.5.
Statistical analysis was performed with Stata/SE version10.1 (StataCorp LP, College Station, Tex). Categorical variables were evaluated using a Fisher exact test, and continuous variables were compared using a Student t-test. A logistic regression model was used to evaluate the association of risk factors with LEW. A P value < .05 was considered statistically significant.
RESULTS
Between October 17, 2013, and November 23, 2015, 21 patients underwent successful MBEVAR. Two patients had pre-existing paraplegia from prior open aortic surgery and were excluded from the current analysis. The mean age was 72.6 6 8.3 years, and 15 of 19 (79%) were men. All patients had a history of hypertension, and 6 of 19 (32%) had a history of prior transient ischemic event (n ¼ 1) or stroke (n ¼ 5); 3 of 19 (16%) had diabetes, but none of them were taking insulin preoperatively. The mean maximum aneurysm diameter was 65 6 9 mm, and 9 of 19 (47%) had a type IV TAAA (n ¼ 5) or PRAA (n ¼ 4; Table I ). All patients with type IV TAAA or PRAA, except for one, had implantation of a four-branched stent graft. The sole exception was a patient with a single patent renal artery, who underwent placement of a three-branched stent graft. The proximal seal zone was in the supraceliac aorta in all patients with type IV TAAA or PRAA. Ten patients (53%) had prior thoracic or abdominal aortic surgery. No patient woke up from anesthesia with a neurologic deficit. LEW developed in 7 of 19 patients (37%) in the postoperative period. This was temporary in 5 of 19 (26%) patients and permanent in 2 of 19 (11%) patients (Table II) . The two patients with permanent neurologic deficits were both paraplegic. One of these patients developed paraplegia 4 hours after the conclusion of the procedure. He had minimal improvement in his lower extremity motor function despite aggressive CSF drainage, fluid resuscitation, and blood pressure augmentation. The other patient had normal bilateral lower extremity motor function until he sustained a cardiopulmonary arrest after administration of narcotic medication for pain. He was successfully resuscitated but had permanent bilateral lower extremity paralysis after approximately 15 minutes of cardiopulmonary resuscitation. All patients with LEW were discharged from the hospital and alive within 30 days after MBEVAR.
In the LEW group, three of seven patients (43%) had Crawford type III TAAA and four of seven patients (57%) had type IV TAAA or PRAA. No patients with types I, II, or V TAAA developed LEW (Table III) . The LEW group was older than the non-LEW group (76.7 6 6.3 vs 70.2 6 8.6 years, respectively; P ¼ .10), had a lower preoperative glomerular filtration rate (GFR; 58.6 6 18.5 vs 71.4 6 23.5 mL/min per 1.73 m 2 , respectively; P ¼ .24), and was more likely to be taking a statin (100% vs 67%; P ¼ .13), but these did not reach statistical significance. There was no significant difference in the prevalence of diabetes mellitus, cardiac disease, lung disease, smoking history, or peripheral artery disease (P > .30 for each) in the LEW and non-LEW groups. There was also no significant difference in preoperative aneurysm diameter, history of prior aortic surgery, operative time, blood loss, contrast material volume, fluoroscopy times, or intraoperative CSF drainage (P > .30 for each) in the LEW and non-LEW groups.
There was no significant difference in preoperative blood glucose levels in those with and without LEW (117 6 20 vs 108 6 27 mg/dL, respectively; P ¼ .44). Blood glucose levels increased in both groups postoperatively, peaking in the immediate postoperative period and trending down by POD 1. Patients with LEW had significantly higher blood glucose levels on POD 1 compared with those without LEW (Table IV; Fig 1) .
Although the preoperative CSF glucose levels were higher in those with LEW compared with those without LEW, these values were not significantly different (67 6 13 vs 57 6 15 mg/dL, respectively; P ¼ .17). CSF glucose levels increased in both groups postoperatively and still appeared to be rising as of POD 1 (Fig 2) . Patients with LEW had significantly higher CSF glucose levels on POD 1 compared with those without LEW (Table IV ; Fig 2) . In all patients with LEW, the elevation in the blood and CSF glucose levels preceded the development of LEW.
There was no significant difference in preoperative CSF lactate levels in those with and without LEW (1.6 6 0.2 vs 1.4 6 0.3 mmol/L, respectively; P ¼ .16). The CSF lactate levels rose in both groups during the postoperative period and still appeared to be rising as of POD 1 (Fig 3) . Immediately after the operation and on POD 1, lactate levels in the CSF were significantly higher in those patients who developed LEW compared with those who did not develop LEW (Table V; Fig 3) . A logistic regression model was used to determine the association between risk factors and LEW. Risk factors on univariate analysis associated with LEW with a P value < .25 were included in a multivariable regression model. This included age (P ¼ .11) and baseline estimated GFR (eGFR; P ¼ .23). Because the glucose and lactate values at multiple different time points met this criterion, we chose to include CSF glucose (P ¼ .02), blood glucose (P ¼ .04), and CSF lactate (P ¼ .05) at the POD 1 time point in separate multivariable models (to avoid overadjustment). In a multivariable model that included age, eGFR, and CSF glucose level on POD ] per 10 mg/dL increase in CSF glucose level; P ¼ .04). In separate models, blood glucose level on POD 1 was associated with a 2.50 increased odds of LEW per 10 mg/dL (95% confidence interval, 0.95-6.53; P ¼ .06), and CSF lactate level on POD 1 was associated with a 1.59 increased odds of LEW per 0.1 mmol/L (95% confidence interval, 0.92-2.74; P ¼ .10). In the last two models, age and eGFR were not significantly associated with LEW.
DISCUSSION
Despite the application of lessons learned from both open and endovascular TAAA repair, SCI remains a serious and common complication after surgical treatment of the thoracoabdominal aorta. Adjunctive procedures to maintain collateral blood flow to the spinal cord, routine CSF drainage, avoidance of hypotension, and staged repair have resulted in a decline in paraplegia rates. 4, 9, 10, 29 However, even with institution of all of these measures, permanent LEW still occurs in approximately 10% of patients undergoing complex endovascular thoracoabdominal aortic procedures, and the rates of transient LEW are even higher. 4, 7, 8 Hyperglycemia occurs in approximately 40% of patients after an ischemic stroke. 30, 31 The presence of hyperglycemia is associated with infarct expansion, worse functional outcome, and increased mortality. [14] [15] [16] [17] Possible mechanisms of hyperglycemia-mediated damage include anaerobic glucose metabolism leading to increased lactate acid production, generation of free radicals, mitochondrial dysfunction, inflammation, and disruption of the blood-brain barrier. [18] [19] [20] [21] [32] [33] [34] Although hyperglycemia is associated with worse clinical outcomes in the setting of ischemic stroke, it is not clear whether interventions to maintain euglycemia are protective. This is currently the topic of study in the Stroke Hyperglycemia Insulin Network Effort (SHINE) trial, which is a multicenter, randomized, controlled clinical trial evaluating the safety and efficacy of targeted glucose control (80-130 mg/dL) compared with control (target glucose <180 mg/dL) after acute ischemic stroke. 35 The association between hyperglycemia and spinal cord injury has been examined in animal studies. Kobayakawa et al demonstrated that hyperglycemic mice had more severe motor deficits compared with normoglycemic mice during acute SCI. 25 They found overexpression of inflammatory cytokines by the microglia as well as an increase in the extrinsic pathway of neuronal apoptosis in the hyperglycemic mice. In this study, the detrimental effects of hyperglycemia were prevented by normalizing the blood glucose concentration with insulin injection during the acute phase of SCI. In a rat spinal tumor model, hyperglycemia shortened the time to paralysis; in addition, a lower epidural tumor volume was required to cause paralysis in hyperglycemic rats.
26
Human studies examining the association between hyperglycemia and outcomes after spinal injuries are mainly limited to retrospective analyses. One review from a registry at a level 1 trauma center in Australia found hyperglycemia (at the time of injury) to be associated with subsequent functional disability and suboptimal physical health status in patients with spine injuries. 36, 37 Another review of 528 patients with SCI demonstrated that hyperglycemia on admission (glucose concentration $126 mg/dL) was a significant predictor of poor functional outcome. 25 It remains to be determined whether hyperglycemia actually exerts direct detrimental effects on neuronal tissue and therefore worsens clinical outcomes or if it is simply a marker of severe injury. Several studies have examined the association between CSF neuronal biomarkers and SCI after endovascular aortic repair, but we did not identify any studies that analyzed CSF glucose or lactate levels. 38 (2) higher CSF glucose levels after 60 minutes of aortic clamping compared with those without postoperative neurologic deficits. 40 We found blood and CSF glucose levels to be significantly higher on the morning of POD 1 in those with LEW compared with those without LEW. The fact that increased blood or CSF glucose levels preceded the development of LEW suggests that abnormal glucose metabolism may be a causative factor in the development of LEW. If this is the case, tight glucose control may help reduce the incidence of LEW not only in a high-risk TAAA population but also in the larger group of patients undergoing endovascular treatment of thoracic aortic aneurysms or dissections. On the basis of the findings of our study, we have instituted a change in the postoperative management of patients undergoing MBEVAR. All patients who undergo MBEVAR are now placed on a standard inpatient adult critical care insulin infusion protocol that is continued for the first 48 hours after surgery. A blood glucose level is checked immediately on arrival to the intensive care unit, and a regular insulin intravenous infusion is begun if the blood glucose level is $120 mg/dL. We also found CSF lactate levels to be significantly higher in the postoperative period in those with LEW compared with those without LEW. This was not a surprising finding as lactic acid is the product of anaerobic glucose metabolism. Although neurologic damage markers such as neurofilament light, total-tau, and S-100 beta protein are associated with SCI after endovascular TAAA repair, these biomarkers rise too slowly and only after SCI has occurred to be useful to guide therapeutic strategies. 38 The ideal biomarker is one that can be quickly measured in any hospital laboratory and is elevated before the clinical manifestations of SCI. Blood and CSF glucose levels and CSF lactate levels meet most of these criteria, but CSF glucose concentration was the only marker that was significantly and independently associated with postoperative LEW in a multivariable model. One strength of this study is that this was a cohort at high risk for SCI, given the extensive aortic coverage required for endovascular PRAA and TAAA repair in patients with a significant rate (nearly 60%) of previous aortic surgery. This allowed us to identify significant associations between blood and CSF glucose levels and CSF lactate levels in those with and without postoperative LEW. Another strength of the study is that the MBEVAR technique and perioperative care for these patients remained stable and consistent throughout the course of this study, allowing us to evaluate risk factors not dependent on the impact of changes in technique or protocol. One big limitation of this study is the small size of the cohort. Another limitation is that the patients were not routinely evaluated preoperatively or postoperatively by a neurologist, so minor neurologic deficits may have been missed.
CONCLUSIONS
Despite refinement in the technique for MBEVAR (staged repair, shorter fluoroscopy times), routine CSF drainage, avoidance of hypotension, and close monitoring for neurosensory symptoms, LEW still remains a problem. Patients with elevated postoperative blood and CSF glucose levels appear to be at higher risk for the development of LEW. It is not clear whether elevated glucose levels are simply a marker of increased risk or directly contribute to neuronal injury. If the former is true, then employing a more aggressive protocol for CSF drainage or blood pressure augmentation may be indicated in this subgroup of high-risk patients. If the latter is true, the potential protective effect of euglycemia deserves further study. 
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